GALLO, Ciro
 Distribuzione geografica
Continente #
NA - Nord America 4.520
EU - Europa 4.499
AS - Asia 516
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 5
AF - Africa 4
OC - Oceania 4
Totale 9.553
Nazione #
US - Stati Uniti d'America 4.508
IE - Irlanda 1.457
UA - Ucraina 875
GB - Regno Unito 601
DE - Germania 540
CN - Cina 346
IT - Italia 318
SE - Svezia 238
FI - Finlandia 218
GR - Grecia 140
TR - Turchia 132
FR - Francia 46
BE - Belgio 20
AT - Austria 13
IR - Iran 11
CA - Canada 10
IN - India 8
CH - Svizzera 6
EU - Europa 5
NL - Olanda 5
ES - Italia 4
PH - Filippine 4
SG - Singapore 4
BG - Bulgaria 3
KR - Corea 3
RS - Serbia 3
TW - Taiwan 3
AU - Australia 2
BF - Burkina Faso 2
BR - Brasile 2
EG - Egitto 2
HU - Ungheria 2
NZ - Nuova Zelanda 2
PL - Polonia 2
PT - Portogallo 2
RO - Romania 2
TH - Thailandia 2
AR - Argentina 1
CO - Colombia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
ID - Indonesia 1
JP - Giappone 1
MT - Malta 1
MX - Messico 1
NO - Norvegia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 9.553
Città #
Dublin 1.456
Jacksonville 1.276
Chandler 859
Princeton 235
Bremen 221
Medford 208
Boardman 153
San Mateo 135
Ann Arbor 124
Wilmington 120
Roxbury 117
Beijing 102
Ashburn 95
Woodbridge 85
Caserta 53
Jinan 48
Des Moines 46
Mountain View 41
Cambridge 39
Nanjing 34
Houston 25
Zhengzhou 20
Brussels 19
Norwalk 19
New York 18
Düsseldorf 17
Napoli 16
Nanchang 15
Ningbo 14
Vienna 13
Campodarsego 11
Scottsdale 11
Shenyang 11
Dearborn 10
Haikou 10
Helsinki 10
Changsha 9
Kunming 9
Padova 9
Venice 9
Los Angeles 8
Redwood City 8
Guangzhou 7
Hangzhou 7
Taiyuan 7
Tianjin 7
Hebei 6
Lanzhou 6
Naples 6
Ponte San Pietro 6
Rome 6
Taizhou 6
Auburn Hills 5
Bari 5
Bologna 5
Fairfield 5
Munich 5
Sant'antimo 5
Cantù 4
London 4
Orange 4
Seattle 4
Zanjan 4
Abbiategrasso 3
Calgary 3
Cattolica 3
Guido 3
Jiaxing 3
Lipa City 3
Namakkal 3
Philadelphia 3
San Rafael 3
Serravalle Pistoiese 3
Tappahannock 3
Acerra 2
Aci Catena 2
Andover 2
Aversa 2
Bergamo 2
Burnips 2
Caltanissetta 2
Castelnuovo Rangone 2
Catanzaro 2
Changchun 2
Chiang Mai 2
Falls Church 2
Frankfurt am Main 2
Fuzhou 2
Groningen 2
Haiger 2
Kraków 2
Lappeenranta 2
Livigno 2
Marano Di Napoli 2
Matera 2
Mcallen 2
Milan 2
New Taipei 2
Ouagadougou 2
Pamplona 2
Totale 5.937
Nome #
A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients 155
Association between thraetened pre-term labour and periodontal disease: does a relationship exist? A matched case-control study 101
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 88
Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial 85
Symptomatic Toxicities Experienced During Anticancer Treatment: Agreement Between Patient and Physician Reporting in Three Randomized Trials 75
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): A randomised, multicentre, open-label, phase 3 trial 74
null 73
Prognostic value of circulating tumor cells' reduction in patients with extensive small-cell lung cancer 68
Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial 67
Epidemiology of chronic kidney disease in Italy: the CARHES study 65
First-Line Erlotinib Followed by Second-Line Cisplatin- Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The TORCH Randomized Trial 62
Epidemiological study on behavioural and emotional problems in developmental age: prevalence in a sample of Italian children, based on parent and teacher reports. 61
Efficacia e sicurezza della combinazione colistina-rifampicina in confronto con la colistina in monoterapia nelle infezioni gravi da Acinetobacter baumannii MDR: risultati preliminari 61
Cisplatin in addition to single-agent first-line chemotherapy in elderly patients with advanced non-small-cell lung cancer (NSCLC): efficacy results of a joint analysis of the multicentre, randomized phase 3 MILES-3 and MILES-4 studies 61
An international, multicenter, randomized phase III study of first-line erlotinib followed by second-line cisplatin/gemcitabine versus first-line cisplatin/gemcitabine followed by second-line erlotinib in advanced non-small-cell lung cancer: treatment rationale and protocol dynamics of the TORCH trial 59
Chronic active hepatitis in Italy: a multicentric study on clinical and laboratory data of 1151 cases. A report from the study group for CAH of the Italiana Association for the Study of the Liver 59
Survival after locoregional treatments for hepatocellular carcinoma: a cohort study in real-world patients. 59
Hepatic resection and percutaneous ethanol injection as treatments of small hepatocellular carcinoma. A Cancer of the Liver Italian Program (CLIP 08)retrospective case-control study 58
Management of hypertension in chronic kidney disease: the Italian multicenter study. 57
Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP) 57
Consumi, abitudine e atteggiamentei verso alcool, tabacco e caffé. Indagine campionaria in una USL napoletana 57
Dental occlusion and body posture in growing subjects. A population-based study in 12-year- old Italian adolescents 57
Rationale and Design of MILES-3 and MILES-4 Studies: Two Randomized Phase 3 Trials Comparing Single-Agent Chemotherapy Versus Cisplatin-Based Doublets in Elderly Patients With Advanced Non-Small-Cell Lung Cancer 56
Differenti modalità di classificazione e significato prognostico delle aritmie ventricolari dopo infarto acuto del miocardio 56
Adjuvant therapy with tamoxifen in operable breast cancer. 10 year results of the Naples (GUN) study 56
Prognostic significance of circulating immune complexes in a long-term follow-up of breast cancer patients 55
Cetuximab and gemcitabine in elderly or adult PS2 patients with advanced non-small-cell lung cancer: The cetuximab in advanced lung cancer (CALC1-E and CALC1-PS2) randomized phase II trials 55
Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial 54
Management of hypertension in chronic kidney disease: the italian multicentric study 53
A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial 53
Carboplatin plus vinorelbine plus G-CSF in elderly patients with extensive-stage small-cell lung cancer: a poorly tolerated regimen. Results of a multicentre phase II study 53
La richiesta del consenso nelle sperimentazioni cliniche controllate 53
Health effects associated with the disposal of solid waste in landfills and incinerators in populations living in surrounding areas: a systematic review 53
Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study. 52
Validation by calibration of the UCLA integrated staging system prognostic model for nonmetastatic renal cell carcinoma after nephrectomy 52
Application of a statistical approach to determining reference intervals in clinical chemistry 52
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials 52
Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer. 51
A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study 51
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial. 51
Is human hepatocellular carcinoma a hormone-responsive tumor? 51
The role of surgery in transmitting "post-transfusion" hepatitis 51
Fattori di rischio per l'infezione tifoidea nell'area geografica del golfo di Napoli 51
Atti del Convegno della Società Italiana di Statistica Medica ed Epidemiologia Clinica 51
Prognosis of CKD Patients Receiving Outpatient Nephrology Care in Italy 51
Early PET/CT Scan Is More Effective Than RECIST in Predicting Outcome of Patients with Liver Metastases from Colorectal Cancer Treated with Preoperative Chemotherapy Plus Bevacizumab 51
Morbidity patterns in aged population in southern Italy. A survey sampling 50
Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: Safety data from the multicentre phase 3 randomised ELDA trial 50
Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study 50
Informed versus randomised consent to clinical trials 50
CMF vs alternating CMF/EV in the adjuvant treatment of operable breast cancer. A single centre randomised clinical trial (Naples GUN-3 study) 50
A multivariate strategy for the statistical treatment of chemico-clinical data and the construction of reference regions 50
Analisi dei potenziali fattori di distorsione ('bias') operanti nello studio della storia naturale della epatite cronica persistente da HBV 50
Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACC 50
The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy. 50
Immunosuppressive therapy of HBsAg-positive chronic active hepatitis in childhood: a multicentric restrospective study on 139 patients 49
Off-label prescription of antineoplastic drugs: an Italian prospective, observational, multicenter survey 49
Il rischio di complicanze nel paziente operato: problemi metodologici 49
Adjuvant chemoendocrine therapy for early breast cancer: is it worthwhile? 49
A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme) 49
A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients: The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial 49
Individual patient data meta-analysis of docetaxel administered once every 3 weeks compared with once every week second-line treatment of advanced non-small-cell lung cancer 48
Chemotherapy-induced neutropenia: a useful predictor of treatment efficacy? 48
A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) group 48
Valutazione prognostica dei pazienti sopravvissuti ad infarto acuto del miocardio: analisi uni- e multivariata 48
Comparison of predictive accuracy of four prognostic models fr non-metastatic renal cell carcinoma after nephrectomy. A multicentre European study 48
Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: Joint Analysis of MILES-3 and MILES-4 Phase III Trials 48
Reply to V. Lorusso et al. 47
Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study 47
Survey of modalities of toxicity assessment and reporting in noncomparative prospective studies of chemotherapy in breast cancer 47
Hormonal treatment of human hepatocellular carcinoma 47
Definizione di un indice prognostico multifattoriale della mortalità postoperatoria 47
Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer: the randomized phase 3 HOBOE study 47
Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data 46
Time spent for activation of non-profit studies in oncology in Italy 46
Valutazione ed interpretazione di un indice prognostico multifattoriale di rischio chirurgico 46
La determinazione della statura attraverso la lunghezza radiografica del radio e dell'ulna 46
Antiproteinuric Response to Dual Blockade of RAS in Primary Glomerulonephritis: Meta-Analysis and Meta-Regression 46
Studio epidemiologico sul consumo di alcool, tabacco e caffé in una ISL napoletana 46
Comparaison de la précision predictive de quatre modèles pronostiques dans le cancer du rein localisé 46
High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study. 46
Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group 45
Tamoxifen in the treatmnent of hepatocellular carcinoma: 5 years results of the CLIP-1 multicentre randomised controlled trial 45
Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer 45
Etiological, clinical and laboratory data of post-transfusion hepatitis: a retrospective study of 379 cases from 53 Italian hospitals 45
Confronto dell’accuratezza predittiva di quattro modeli prognostici per il carcinoma renale non metastatico. Uno studio multicentrico europeo 45
Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-alpha in advanced malignant melanoma 45
Il gioco dell'oca 45
Postfazione 45
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials 45
Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study 44
Carboplatin plus Vinorelbine, a new well tolerated and active regimen for the treatment of extensive-stage small-cell lung cancer: a phase II study 44
Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial 44
Prevalence of varicose veins in an Italian elderly population 44
Phase I study of carboplatin, cisplatin and cyclophosphamide without and with lenogastrim for the treatment of ovarian cancer 44
Endocrine factors in the outcome of systemic adjuvant therapy of early breast cancer 44
A prognostic index for patients within the intermediate stage of hepatocellular carcinoma 44
Treatment withdrawal in relapsing-remitting multiple sclerosis: a retrospective cohort study 44
Clinical and histological aspects of chronic HCV infection and cirrhosis 43
Assessing Financial Toxicity in Patients With Cancer: Moving Away From a One-Size-Fits-All Approach 43
Totale 5.348
Categoria #
all - tutte 35.426
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.426


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201928 0 0 0 0 0 0 0 0 0 0 15 13
2019/20201.249 259 220 11 5 210 25 238 48 121 44 56 12
2020/20211.858 186 10 212 94 379 25 237 202 19 257 189 48
2021/20221.315 144 4 3 21 482 5 24 38 46 65 102 381
2022/20233.048 262 55 31 297 435 264 4 178 1.389 17 49 67
2023/2024819 105 38 102 101 385 30 18 14 3 20 3 0
Totale 9.767